Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-25-000129
Filing Date
2025-02-13
Accepted
2025-02-13 12:32:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12952
2 verastem99.htm EX-99 4983
  Complete submission text file 0000935836-25-000129.txt   19654
Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541-647-5673
Stonepine Capital Management, LLC (Filed by) CIK: 0001440771 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Subject) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86603 | Film No.: 25618649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)